Mgr. Hana Filková
Instructor, Institute of Medical Genetics and Genomics
Phone: | +420 532 23 4745 |
---|---|
E‑mail: |
Total number of publications: 79
2007
-
Newly Diagnosed Multiple Myeloma Patients with 1q21 Amplification Treated by Autologous Stem Cell Transplantation Have Shorter Progression-Free Survival Interval
Blood 2007, Vol.110(11) Part 2, year: 2007
-
Prognostic impact of 1q21 amplification for newly diagnosed and relapsed/refractory multiple myeloma patients enrolled in Brno, Czech Republic.
From cell sorting to plasma cell identification and detection chromosomal aberrations in multiple myeloma. Abstract and Application Manual, year: 2007
-
Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy
Blood Reviews, year: 2007
-
Prognostic impact of unfavorable cytogenetic abnormalities in multiple myeloma patients treated by bortezomib (velcade)
Hematologica/The Hematology Journal, year: 2007
-
Prognostic value of selected chromosomal abnormalities in multiple myeloma patients treated by thalidomide
Haematologica, year: 2007
-
Prognostický význam amplifikace 1q21 u pacientů s mnohočetným myelomem léčených bortezomibem (Velcade), thalidomidem (Myrin) a konvenční chemoterapií
Year: 2007, type: Conference abstract
-
Prospective comparison of response rate and long-term results of Velcade and thalidomid based regimens
Haematologica/The Hematology Journal, 2007; Vol.92(6) suppl.2, year: 2007
-
Vztah vybraných cytogenetických markerů k histopatologickému vyšetření a prognóze u pacientů s meduloblastomem
Year: 2007, type: Conference abstract
2006
-
Correlation between the cytogenetic findings and the prognostic factors in the group of patiens from the CMG 2002 clinical study
Year: 2006, type: Conference abstract
-
Detection of chromosomal aberrations in multiple myeloma
Year: 2006, type: Workshop